News

Wellinks Raises $25M to Boost Access to Its Digital Healthcare Tools

Wellinks, a digital healthcare company, has closed a $25-million funding round to expand access to its integrated, virtual management system for chronic obstructive pulmonary disease (COPD). It offers a combination of pulmonary rehabilitation with personalized coaching and monitoring through connected devices, such as the Flyp nebulizer, spirometer, and…

Dark-Field Chest X-rays Could Improve Diagnosis, Early Detection

Dark-field chest X-ray imaging provides greater detail of lung microstructure than standard chest X-rays, and allows for the accurate diagnosis of chronic obstructive pulmonary disease (COPD), a study shows. “In the future dark-field X-rays could help improve early detection of COPD and other respiratory ailments,” Alexander Fingerle, MD, of the…

Lace Up, Don Orange to Support COPD Awareness in November

Sporting the color orange and “lacing up” for patients, supporters nationwide are participating in COPD Awareness Month, observed each November to call attention to the lung disorder that affects nearly 16 million U.S. residents, with millions more undiagnosed. World COPD Day is Nov. 17. Awareness and education are crucial…

Grants Awarded to Gut Microbiome, Influenza Research in Australia

Researchers at the Centenary UTS Centre for Inflammation in Australia have been awarded grants to investigate potential therapeutics for respiratory conditions like chronic obstructive pulmonary disease (COPD). One of the awards is a $5-million National Health and Medical Research Council (NHMRC) Synergy Grant that will investigate methods in…

Antioxidant NAC Found to Ease Lung Scarring in Preclinical Study

Treatment with the antioxidant N-acetylcysteine (NAC) lowered blood levels of pro-inflammatory molecules and reduced lung scarring, or fibrosis, in a rat model of chronic obstructive pulmonary disease (COPD), a study shows. This beneficial effect was associated with the suppression of two molecules — von Willebrand factor (VWF) and p38 mitogen-activated…

Treatment With pMDI Ensifentrine Found to Improve Lung Function

Seven days of treatment with ensifentrine, given using a pressurized metered-dose inhaler — called a pMDI — resulted in marked lung function improvements in people with moderate to severe chronic obstructive pulmonary disease (COPD), according to data from a Phase 2 clinical trial. “This study demonstrates that ensifentrine administered…

Hemoglobin May Be Promising Biomarker of Clinical Outcomes

Hemoglobin, the protein that carries oxygen in blood, may be a promising biomarker to assess the clinical outcomes of patients with chronic obstructive pulmonary disease (COPD), a large U.S.-based study has found. The findings indicate that unusually high or low levels of hemoglobin were linked to worse clinical outcomes.